Syngene International Limited has completed the acquisition of a biologics manufacturing facility from Emergent BioSolutions Inc. for USD 36.5 million, enhancing its bioreactor capacity to 50,000L, as announced on March 10, 2025.
AI Assistant
Syngene International Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.